Brimonidine tartrate

Ophthalmic solution in concentrations up to and including 0.025%, used for the relief of redness of the eye due to minor eye irritations caused by environmental allergies, dryness and fatigue for adults of 18 years and older

Approval Date: January 23, 2024

Schedule: U

Footnote: